NIH-funded research R01 grant

Investigating cholesterol metabolism in aggressive colorectal cancer

Official title: Cholesterol metabolism in mesenchymal colorectal cancer

Funded at Weill Medical Coll of Cornell Univ · NIH-10987036 · Data updated 2026-11-12

This study is looking at how cholesterol affects the growth of a tough type of colorectal cancer, with the goal of finding new ways to treat it, so patients can have better options in the future.

More Colorectal Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startDecember 9, 2022
Project endNovember 30, 2027
Funding year2025
Award (this year)$523,143
NIH project number5R01CA275846-03
Project IDNIH-10987036 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with mesenchymal colorectal cancer, particularly those with a microsatellite stable phenotype.

Less likely to help

Patients with other types of colorectal cancer or those who do not have mesenchymal characteristics may not benefit from this research.

What this research studies

This research focuses on understanding how cholesterol metabolism contributes to the aggressive nature of mesenchymal colorectal cancer (CRC). By identifying specific vulnerabilities in this cancer type, the study aims to develop new therapeutic strategies. The approach involves analyzing human cancer samples and utilizing mouse models to explore the role of certain proteins in cancer progression and cholesterol biosynthesis. Patients may benefit from insights that could lead to more effective treatments for this challenging cancer subtype.

Why it matters

Potential benefit: If successful, this research could lead to new targeted therapies for patients with aggressive mesenchymal colorectal cancer.

How similar studies have gone: Previous research has shown promising results in targeting metabolic pathways in cancer, suggesting potential for success in this novel approach.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Moscat, Jorge — Weill Medical Coll of Cornell Univ
  • Study coordinator: Moscat, Jorge

Related research

Other NIH-funded projects on the same topics.

  • Improving colorectal cancer screening and follow-up care.

    This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.

    NIH research Research Triangle Institute · Research Triangle Park, United States · NIH-9627071

  • Colorectal cancer prognosis through a broad, collaborative study

    A large, multi-center study follows people newly diagnosed with colorectal cancer to find biomarkers and patterns that predict outcomes and guide future care.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11590756

  • Ceramides and how they affect metabolism and colorectal cancer in adults

    A study in adults with obesity-related health issues will explore how a fat-related molecule called ceramide influences metabolic problems and colorectal cancer risk.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11535283

  • Automated point-of-care DNA methylation test for colorectal cancer in LMICs

    A fast, affordable blood test using DNA markers to help identify people at higher risk of colorectal cancer in low- and middle-income countries.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11531863

  • Rewiring Colorectal Cancer to Harness Therapeutic Hyperactivation

    A Yale team is exploring brain-storming new ways to treat colorectal cancer by safely boosting certain cancer signaling pathways to kill cancer cells and by reshaping cancer cell states to improve responses to existing therapies.

    NIH research Yale University · New Haven, United States · NIH-11505210

  • Comparative modeling to guide colorectal cancer screening and care

    A researcher team will use computer models to study how access to care, risk, and new screening options affect colorectal cancer outcomes and costs for adults in the US.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11495363

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.